http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0037091-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1af430ecccde1dd0ea061e6c428c9535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70a5b17ac69a8d8a16ede0ebda6feb7e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-22 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-22 |
filingDate | 1998-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6997b524f29f95ddd50a8e0fa71b683 |
publicationDate | 2000-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-0037091-A1 |
titleOfInvention | Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
abstract | The present invention relates to a pharmaceutical composition for treatment and prevention of cancer and preparation method thereof, especially to a cell differentiation agent which is named CDA-II prepared by extracting and purifying fresh human urine. The pharmaceutical composition is superior in effective for treatment and prevention of cancer. These effective components contain a differentiation inducer, a differentiation adjuvant and an anticachexia agent in CDA-II, and cooperate each other to achieve the best medical effect. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1419779-A1 |
priorityDate | 1998-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 805.